Business Development Manager, Glooko
Real-World Data
+ Pre-IPO stock incentives
Travel as required
Application for diabetes management
Be an early applicant
Application for diabetes management
201-500 employees
Be an early applicant
+ Pre-IPO stock incentives
Travel as required
201-500 employees
Company mission
To enhance the lives of people with chronic conditions by connecting them with their caregivers and equipping both with the tools needed to achieve positive outcomes.
Jump to section
Company mission
To enhance the lives of people with chronic conditions by connecting them with their caregivers and equipping both with the tools needed to achieve positive outcomes.
-4% employee growth in 12 months
Our take
Glooko is a Software-as-a-Service provider that offers diabetes patients and healthcare providers important data. Glooko leverages evolving diabetes information in order to improve patient outcomes and provider access to data, while reducing related costs.
Among the services provided by the company are a patient mobile app, a provider population management app, and a meter sync hardware device. This latter innovation offers both insights on patients’ conditions and an array of population management features.
Glooko is one of many companies in the telehealth environment, but promises to usurp the competition by offering superior coverage and the ability to sync in real-time with diabetes devices. Its partners include Sanofi, Senseonics and other international MedTech brands, and it also acquired Monarch Medical Technologies in order to expand its offerings.
Freddie
Company Specialist at Welcome to the Jungle
Funding (last 2 of 8 rounds)
Oct 2024
$100m
SERIES F
Mar 2021
$30m
SERIES D
Total funding: $207m
This company has top investors
Leadership
Yogen Dalal
(Founder)PhD in Electrical Engineering at Stanford. Co-founder, VP Product Development at Claris. Managing Director at Mayfield Fund. Co-founded Glooko in 2010. Recognised as key figure in founding of internet.
Mike Alvarez
(CEO, President & Board Member)Former CEO, President and Board Member at Qardio. Also spent 12 years at Medtronic, ultimately as US VP.